sellWeak10b5-1 plan
David F Novack sold $471k of DVAX
President & COO at DYNAVAX TECHNOLOGIES CORP. 32,764 shares at an average of $14.39, traded Mar 7, 2025, filed Mar 10, 2025.
Warning score
37Value
$471k
32,764 shares
Holdings after
22,098
-60% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RolePresident
- +17Trade size$471k at market
- +20Share of holdings soldSold 60% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001029142-25-000061, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 7, 2025 | SOpen-market sale Common Stock10b5-1 | -32,764 | $14.39 | $471k | 22,098 | Mar 10, 2025 |
Related signals
Other insiders at DYNAVAX TECHNOLOGIES CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $1.8M 114,000 shares | -64% | |
| 7Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $465k 30,000 shares | -21% | |
| 24Weak | DVAXbuy DYNAVAX TECHNOLOGIES CORP | Scott Dunseth Myers director | $41k 3,800 shares | +12% | |
| 42Moderate | DVAXsell DYNAVAX TECHNOLOGIES CORP | Deep Track Biotechnology Master Fund, Ltd. owner | $22M 2,065,137 shares | -12% | |
| 16Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $140k 10,000 shares | -55% | |
| 32Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $190k 14,020 shares | -63% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.